Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2017, Vol. 11 Issue (3) : 386-392    https://doi.org/10.1007/s11684-017-0574-z
RESEARCH ARTICLE
Clinical characteristics and outcomes of biopsy-proven diabetic nephropathy
Li Zhuo, Nianrong Zhang, Guming Zou, Dapeng Chen, Wenge Li()
Department of Nephrology, China–Japan Friendship Hospital, Beijing 100029, China
 Download: PDF(128 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

Kidney damage is common in patients with diabetes mellitus (DM). However, whether the type of kidney damage can be reliably diagnosed using clinical data alone remains unclear. Predictive factors for diabetic nephropathy (DN) outcomes are also poorly understood. In this study, the clinical manifestations of 111 cases of biopsy-proven DN were described, and the clinical and pathological parameters of patients with different DN outcomes were compared. Results showed that long DM duration (>10 years in 32.4% of patients), severe proteinuria (62.2%), and renal dysfunction (estimated glomerular filtration rate [eGFR]<60 mL/(min·1.73 m2)) (52.3%) did not accurately indicate whether the condition of these patients progressed to DN. Hematuria (48.6%) failed to specify either DN or nondiabetic renal disease. Diabetic retinopathy (78.4%) was a crucial complication in patients with DN. Kaplan–Meier analysis revealed that the renal survival of 53 patients who were diagnosed with DN and were followed up was not significantly associated with glomerular classification (P>0.05). Cox’s regression analysis demonstrated that renal survival time was significantly influenced by sex (b= 1.394, P= 0.038), hematuria (b= 0.036, P= 0.029), and eGFR (b= −0.039, P= 0.002) but was not significantly affected by age, 24 h urinary protein excretion, or glomerular classification (P>0.05). In conclusion, the clinical characteristics of DN vary, and renal biopsy is necessary to determine renal damage patterns. Sex, hematuria, and the eGFR may affect DN outcomes, whereas the glomerular classification may not.

Keywords diabetic nephropathy      clinical characteristics      renal biopsy      outcomes     
Corresponding Author(s): Wenge Li   
Just Accepted Date: 26 July 2017   Online First Date: 14 August 2017    Issue Date: 29 August 2017
 Cite this article:   
Li Zhuo,Nianrong Zhang,Guming Zou, et al. Clinical characteristics and outcomes of biopsy-proven diabetic nephropathy[J]. Front. Med., 2017, 11(3): 386-392.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-017-0574-z
https://academic.hep.com.cn/fmd/EN/Y2017/V11/I3/386
Age (year) 49.9±10.5 24 h urinary protein excretion (g/d)
Males 80 (72.1%) ≥0.3 to<1.0 2 (1.8%)
Females 31 (27.9%) ≥1.0 to<3.5 33 (29.7%)
Duration of diabetes (year) ≥3.5 69 (62.2%)
<5 27 (24.3%) Unknown 5 (4.5%)
≥5 to<10 40 (36.0%) Blood pressure (mmHg)
≥10 to<15 18 (16.2%) Normal 30 (27.0%)
≥15 18 (16.2%) Grade 1 (SBP 140–159 or DBP 90–99) 29 (26.1%)
Unknown 8 (7.2%) Grade 2 (SBP 160–179 or DBP 100–109) 26 (23.4%)
Diabetic retinopathy Grade 3 (SBP≥180 or DBP≥110) 26 (23.4%)
Grade I (no apparent retinopathy) 21 (18.9%) eGFR [mL/(min·1.73 m 2)]
Grade II (mild nonproliferative diabetic retinopathy) 15 (13.5%) CKD1 (GFR≥90) 21 (18.9%)
Grade III (moderate nonproliferative diabetic retinopathy) 33 (29.7%) CKD2 (≥60 but<89) 32 (28.8%)
Grade IV (severe nonproliferative diabetic retinopathy) 17 (15.3%) CKD3a (≥45 but<59) 23 (20.7%)
Grade V (proliferative diabetic retinopathy) 11 (9.9%) CKD3b (≥30 but<44) 13 (11.7%)
Unknown 14 (12.6%) CKD4 (≥15 but<29) 18 (16.2%)
Hematuria (cells/HPF) CKD5 (<15) 4 (3.6%)
<3 57 (51.4%) Glomerular classification of DN
≥3 to<10 34 (30.6%) Class I (mild or nonspecific LM changes and EM-proven GBM thickening) 0 (0%)
≥10 to<50 16 (14.4%) Class IIa (mild mesangial expansion) 26 (23.4%)
≥50 4 (3.6%) Class IIb (severe mesangial expansion) 14 (12.6%)
24 h urinary protein excretion (g/d) Class III (nodular sclerosis: Kimmelstiel–Wilson lesion) 65 (58.6%)
<0.3 2 (1.8%) Class IV (advanced diabetic glomerulosclerosis) 6 (5.4%)
Tab.1  Baseline characteristics of patients at the time of renal biopsy (n = 111)
Dialysis
(19 cases)
No dialysis
(34 cases)
Sex
Male ( n) 15 24
Female ( n) 4 10
Age (year) 50.63±12.67 49.61±12.04
Youth-onset DM ( n) 9 14
Middle- and late-onset DM ( n) 10 20
Glomerular classification ( n)
IIa 5 9
IIb 2 2
III 10 21
IV 2 2
Renal survival duration (year) 2.18±0.41 1.96±0.35
DM duration (year) 10.0±1.45 12.14±1.05
Hematuria (cells/HPF) 9.99±17.16 6.23±7.56
24 h urinary protein excretion (g/d) 6.36±3.17* 4.52±2.70
eGFR [mL/(min·1.73 m 2)] 49.54±29.51 65.42±33.92
Tab.2  Differences between the patients with DN who did and did not progress to dialysis (n = 53)
Fig.1  Survival curves of the patients with glomerular classifications IIa–b and III–IV; Kaplan–Meier analysis.
b P values OR 95% CI for OR
Sex 1.394 0.038 4.032 1.083–15.012
Age 0.022 0.334 1.023 0.977–1.070
Hematuria 0.036 0.029 1.036 1.004–1.070
24-hUpro 0.143 0.052 1.154 0.999–1.333
eGFR -0.039 0.002 0.962 0.939–0.986
Pathology 0.385 0.515 1.470 0.461–4.681
Tab.3  Cox’s regression analysis of renal survival time by clinical data and pathology
19 MiseK, Hoshino J, UbaraY , SumidaK, Hiramatsu R, HasegawaE , YamanouchiM, HayamiN, SuwabeT, Sawa N, FujiiT , OhashiK, HaraS, TakaichiK. Renal prognosis a long time after renal biopsy on patients with diabetic nephropathy.Nephrol Dial Transplant2014; 29(1): 109–118
https://doi.org/10.1093/ndt/gft349 pmid: 24151019
1 MarinoJS, Peterson SJ, LiM , VanellaL, SodhiK, HillJW, Abraham NG. ApoA-1 mimetic restores adiponectin expression and insulin sensitivity independent of changes in body weight in female obese mice.Nutr Diabetes2012; 2(3): e33
https://doi.org/10.1038/nutd.2012.4 pmid: 23169576
2 XuY, WangL, HeJ, BiY, LiM, WangT, WangL, Jiang Y, DaiM , LuJ, XuM, LiY, HuN, LiJ, MiS, ChenCS, Li G, MuY , ZhaoJ, KongL, ChenJ, Lai S, WangW , ZhaoW, NingG; 2010 China Noncommunicable Disease Surveillance Group. Prevalence and control of diabetes in Chinese adults.JAMA2013; 310(9): 948–959
https://doi.org/10.1001/jama.2013.168118 pmid: 24002281
3 CollinsAJ, FoleyRN, HerzogC, Chavers B, GilbertsonD , IshaniA, Johansen K, KasiskeB , KutnerN, LiuJ, St PeterW, Ding S, GuoH , KatsA, LambK, LiS, Roberts T, SkeansM , SnyderJ, SolidC, ThompsonB, Weinhandl E, XiongH , YusufA, ZaunD, ArkoC, Chen SC, DanielsF , EbbenJ, Frazier E, HanzlikC , JohnsonR, SheetsD, WangX, Forrest B, ConstantiniE , EversonS, EggersP, AgodoaL. US Renal Data System 2012 Annual Data Report. Am J Kidney Dis2013; 61(1 Suppl 1): A7, e1–476
https://doi.org/10.1053/j.ajkd.2012.11.031
4 GrossJL, de Azevedo MJ, SilveiroSP , CananiLH, Caramori ML, ZelmanovitzT . Diabetic nephropathy: diagnosis, prevention, and treatment.Diabetes Care2005; 28(1): 164–176
https://doi.org/10.2337/diacare.28.1.164 pmid: 15616252
5 LinYL, PengSJ, FerngSH, Tzen CY, YangCS . Clinical indicators which necessitate renal biopsy in type 2 diabetes mellitus patients with renal disease.Int J Clin Pract2009; 63(8): 1167–1176
https://doi.org/10.1111/j.1742-1241.2008.01753.x pmid: 18422591
6 KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis2007; 49(2 Suppl 2): S12–S154
https://doi.org/10.1053/j.ajkd.2006.12.005 pmid: 17276798
7 World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Report of a WHO Consultation. Part 1, Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, 1999
8 WilkinsonCP, FerrisFL 3rd, KleinRE , LeePP, AgardhCD, DavisM, Dills D, KampikA , PararajasegaramR, Verdaguer JT; Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.Ophthalmology2003; 110(9): 1677–1682
https://doi.org/10.1016/S0161-6420(03)00475-5 pmid: 13129861
9 WhitworthJA; World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension.J Hypertens2003; 21(11): 1983–1992
https://doi.org/10.1097/00004872-200311000-00002 pmid: 14597836
10 StevensLA, Claybon MA, SchmidCH , ChenJ, HorioM, ImaiE, Nelson RG, Van DeventerM , WangHY, ZuoL, ZhangYL, Levey AS. Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities.Kidney Int2011; 79(5): 555–562
https://doi.org/10.1038/ki.2010.462 pmid: 21107446
11 Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).Kidney Int Suppl2009; (113): S1–S130
pmid: 19644521
12 MogensenC. Early diabetic renal involvement and nephropathy. In: Alberti KGMM, Krall LP. The Diabtes Annual. Vol 3. Amsterdam: Elsevier Science publishers, 1987: 306
13 ZhuoL, RenW, LiW, ZouG, LuJ. Evaluation of renal biopsies in type 2 diabetic patients with kidney disease: a clinicopathological study of 216 cases.Int Urol Nephrol2013; 45(1): 173–179
https://doi.org/10.1007/s11255-012-0164-6 pmid: 22467137
14 ZhuoL, ZouG, LiW, LuJ, RenW. Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus.Eur J Med Res2013; 18(1): 4
https://doi.org/10.1186/2047-783X-18-4 pmid: 23432977
15 TervaertTW, Mooyaart AL, AmannK , CohenAH, CookHT, DrachenbergCB , FerrarioF, FogoAB, HaasM, de Heer E, JohK , NoëlLH, Radhakrishnan J, SeshanSV , BajemaIM, BruijnJA; Renal Pathology Society. Pathologic classification of diabetic nephropathy.J Am Soc Nephrol2010; 21(4): 556–563
https://doi.org/10.1681/ASN.2010010010 pmid: 20167701
16 JiaW. Obesity in China: its characteristics, diagnostic criteria, and implications.Front Med2015; 9(2): 129–133
https://doi.org/10.1007/s11684-015-0387-x pmid: 25620117
17 AnY, XuF, LeW, GeY, ZhouM, Chen H, ZengC , ZhangH, LiuZ. Renal histologic changes and the outcome in patients with diabetic nephropathy.Nephrol Dial Transplant2015; 30(2): 257–266
https://doi.org/10.1093/ndt/gfu250 pmid: 25063425
18 HoshinoJ, MiseK, UenoT, Imafuku A, KawadaM , SumidaK, Hiramatsu R, HasegawaE , YamanouchiM, HayamiN, SuwabeT, Sawa N, HaraS , FujiiT, OhashiK, UbaraY, Takaichi K. A pathological scoring system to predict renal outcome in diabetic nephropathy.Am J Nephrol2015; 41(4-5): 337–344
https://doi.org/10.1159/000431333 pmid: 26067713
[1] Min Zhou, Xinxin Zhang, Jieming Qu. Coronavirus disease 2019 (COVID-19): a clinical update[J]. Front. Med., 2020, 14(2): 126-135.
[2] Biqiong Fu, Jie Yang, Jia Chen, Lirong Lin, Kehong Chen, Weiwei Zhang, Jianguo Zhang, Yani He. Preventive effect of Shenkang injection against high glucose-induced senescence of renal tubular cells[J]. Front. Med., 2019, 13(2): 267-276.
[3] Qiuxia Han, Hanyu Zhu, Xiangmei Chen, Zhangsuo Liu. Non-genetic mechanisms of diabetic nephropathy[J]. Front. Med., 2017, 11(3): 319-332.
[4] Tianhua Xu, Zitong Sheng, Li Yao. Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment[J]. Front. Med., 2017, 11(3): 340-348.
[5] Yugang Cheng,Hanxiang Zhan,Lei Wang,Jianwei Xu,Guangyong Zhang,Zongli Zhang,Sanyuan Hu. Analysis of 100 consecutive cases of resectable pancreatic neuroendocrine neoplasms: clinicopathological characteristics and long-term outcomes[J]. Front. Med., 2016, 10(4): 444-450.
[6] Farhad Sahebjam,John M. Vierling. Autoimmune hepatitis[J]. Front. Med., 2015, 9(2): 187-219.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed